Net worth tracking
Login Sign Up
Become a Premium Member
  • All Opinions
  • Top Picks
  • Experts
  • Companies
  • Discover
Watch List
Home » Daily

Vaccine hopes propel markets

Allan Tong Posted On July 15, 2020
0
0
Shares
  • Share On Facebook
  • Tweet It

Markets surged on encouraging results from Moderna‘s COVID-19 vaccine. In the latest tests, the drug produced antibodies to fight the virus, but some people who participated experienced side effects. Crucial phase 3 trials will begin July 27. Moderna shares soared as much as 18% in Wednesday trading, eventually closing near 7%. On Thursday, AstraZeneca and Oxford University will release their own vaccine’s findings. The positive news drove indices up, especially travel stocks like Marriott which jumped almost 8%. The S&P and Dow closed shy of 1% higher while the Nasdaq gained 0.59%. Meanwhile, American banks continued to report, with Goldman Sachs announced that trading revenues doubled. After an early-morning spike, Goldman closed up 1.35%.

Investors set aside worries over the continuing surge in COVID-19 cases across the American sunbelt, including Arizona, Texas and Florida, which altogether have become the world’s new viral hotspot.

In Canada, the TSX climbed 0.97% with real estate and energy leading. The vaccine news coupled with a record 10.7% jump in Canadian factory sales in May were catalysts. Air Canada and Chorus Aviation both soared nearly 14%. Sleep Country rose 12.88%. Weed stocks jumped after news broke of Aurora and Aphria talking about a merger, though talks broke down late last week. The two cannabis stocks climbed around 7.7%

💉 Moderna +7%
🏢 Marriott International Inc. +8%
🏛 Goldman Sachs +1.35%
🛫 Air Canada +14%
🛫 Chorus Aviation Inc +14%
🛏 Sleep Country Canada Holdings +12.88%
🌿 Aurora Cannabis +7.7%
🌿 Aphria Inc +7.7%

0
Shares
  • Share On Facebook
  • Tweet It




Trending Now
FedEx, Aritzia Inc. and 17 Stock and 3 ETF Top Picks (Jun 24-30)
Melisa R. H. July 1, 2022
3 gems from the Collision technology conference
Allan Tong June 29, 2022
Markets step back, Netflix disappoints
Read Next

Markets step back, Netflix disappoints

  • We're the Stock Chasers
    Hi! We are the Stock Chasers. We write about investing and finance tools we love. We’re passionate about fintech and we invest almost all our affiliate and advertising revenues into the development of Stockchase and Wealthica. We hope you enjoy the stock ideas and product reviews!
  • Top Reviews

    • Questrade Review: Pros & Cons of Trading with Questrade Canada (2021)
      8.5
    • Questrade vs Others | The Review Competitors Don’t Want you to Read (2021)
      7.4
    • The Ugly Truth About Identity Theft – Free Credit Report
      7
  • Popular Posts

    • FedEx, Aritzia Inc. and 17 Stock and 3 ETF Top Picks (Jun 24-30)
    • 3 gems from the Collision technology conference
    • Intertape Polymer Group and More at 52-week Highs & Lows (Jun 22-28)
    • 3 defensive stocks to find stability with your money
    • Markets slide on recession fears
  • Stock Lists

    • 3 defensive stocks to find stability with your money
      June 21, 2022
    • 3 rock stars of the mineral stocks
      June 15, 2022
    • 3 stocks to profit from revenge travel
      June 7, 2022
    • Are tech stocks alive?
      May 31, 2022
    • 3 dividend stocks to fight inflation
      May 24, 2022


  • Get $50 in free trades.


  • Stockchase neither recommends nor promotes any investment strategies.

    About us : Privacy & Terms : Contact us

© Stockchase Inc.
Press enter/return to begin your search